AGS Cells

AGS cells are a human gastric adenocarcinoma cell line derived from the stomach tissue of a 54-year-old Caucasian female. They are extensively used in biomedical research focused on gastric cancer, including studies on cancer cell biology, pathogenesis, and drug testing. The AGS cell line exhibits epithelial-like morphology and is characterized by its aggressive growth pattern and tumorigenic potential in vivo. These cells are commonly used as a model to study the molecular and cellular mechanisms underlying gastric carcinogenesis, including the influence of Helicobacter pylori infection, a well-known risk factor for gastric cancer. AGS cells provide a robust system to explore the interactions between gastric cancer cells and H. pylori, especially regarding how bacterial factors affect cancer cell proliferation, apoptosis, and inflammatory responses. AGS cells are also valuable for examining the gastric epithelial barrier's response to various stimuli, including inflammatory cytokines, and for studying signaling pathways implicated in gastric cancer, such as those involving NF-kB, Wnt, and MAPK. Their utility extends to the assessment of new therapeutic agents, where they are used to evaluate the efficacy and mechanisms of action of anticancer drugs, targeted therapies, and natural compounds with potential anti-cancer properties. Furthermore, AGS cells are often employed in studies aimed at understanding the genetic and epigenetic alterations in gastric cancer, offering insights into potential diagnostic markers and therapeutic targets for this challenging and frequently fatal disease.